Jyong Biotech Ltd. (MENS) News
Follow Jyong Biotech Ltd. (MENS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
MENS says MCS-2 advances with FDA phase III approval
The company says MCS-2 advanced with FDA phase III approval for benign prostatic hyperplasia, and it describes the drug as a botanical option with a strong safety profile.
REGULATION | Sep 07, 2026, 01:33 AM UTC
L
Jyong Biotech to participate in StockFan virtual investor roadshow
Jyong Biotech Ltd. said it will participate in a StockFan virtual investor non-deal roadshow, according to a Globe Newswire announcement.
GEOPOLITICS | Sep 03, 2026, 12:08 PM UTC
L
Jyong Biotech to participate in StockFan virtual investor roadshow
Jyong Biotech says it will take part in a StockFan virtual investor non-deal roadshow.
EQUITY | Sep 03, 2026, 12:02 PM UTC